The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Diversified Trust Co

Diversified Trust Co lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 10.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,049 shares of the medical device company’s stock after purchasing an additional 892 shares during the quarter. Diversified Trust Co’s holdings in Cooper Companies were worth $999,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Quantbot Technologies LP purchased a new position in shares of Cooper Companies in the 1st quarter worth $2,211,000. Whittier Trust Co. raised its position in shares of Cooper Companies by 298.9% in the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock worth $1,211,000 after buying an additional 8,947 shares during the period. Envestnet Portfolio Solutions Inc. raised its position in shares of Cooper Companies by 43.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after buying an additional 10,616 shares during the period. Gulf International Bank UK Ltd raised its position in shares of Cooper Companies by 300.0% in the 1st quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock worth $1,739,000 after buying an additional 12,861 shares during the period. Finally, Axxcess Wealth Management LLC raised its position in shares of Cooper Companies by 298.4% in the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after buying an additional 6,150 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Up 0.1 %

Shares of NASDAQ COO opened at $105.61 on Wednesday. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $112.38. The firm has a market cap of $21.03 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 2.63 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The stock’s 50-day simple moving average is $101.95 and its 200-day simple moving average is $96.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm earned $0.84 earnings per share. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the topic of several research reports. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Morgan Stanley raised their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Robert W. Baird raised their price objective on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Wells Fargo & Company raised their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.